American Society of Gene & Cell Therapy 25th Annual Meeting

Title: Muscle-Specific Tyrosine Kinase Chimeric Autoantibody Receptor T Cells (MuSK-CAART): A Precision Cellular Immunotherapy for Antigen-Specific B Cell Depletion in MuSK Myasthenia Gravis
Session Title: Musculo-skeletal Diseases
Abstract Number: 29
Date and Time: Monday, May 16, 2022, 10:15 a.m. – 10:30 a.m. ET
Location: Salon G
Presenter: 
Sangwook Oh, Ph.D., a Senior Research Investigator in Dr. Payne’s lab at the University of Pennsylvania

Title: A Phase 1 Trial of Targeted DSG3-CAART Cell Therapy in Mucosal-Dominant Pemphigus Vulgaris (mPV) Patients: Early Cohort Data
Abstract Number: 793
Poster Number: Tu-298
Date and Time: Tuesday, May 17, 2022, 5:30 p.m. – 6:30 p.m. ET
Presenter: David J. Chang, M.D., Chief Medical Officer at Cabaletta Bio

Title: Characterization of DSG3-CAART Cells Prior to & Following Adoptive Transfer in Mucosal Pemphigus Vulgaris
Abstract Number: 698
Poster Number: Tu-203
Date and Time: Tuesday, May 17, 2022, 5:30 p.m. – 6:30 p.m. ET
Presenter: Samik Basu, M.D., Chief Scientific Officer at Cabaletta Bio